About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pathway to Diagnosis of Ovarian Cancer

NCT01061619·30 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Cancer Institute, Naples

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Histological diagnosis of ovarian cancer
Indication for chemotherapy
Age \> 18 years
Signed informed consent

You may not be if

Previous chemotherapy
Unable or unwilling to participate in interview

The record

StatusUnknown

PhaseNo phase

Taking part400

StartedJan 2010

UpdatedMar 24, 2023

Conditions

Where30

UZ Leuven-Gynecological Oncology,
Leuven, Belgium
Charité Universitätsmedizin Berlin Campus Virchow-Klinikum / Frauenklinik
Berlin, Germany
IRCCS Oncologico Bari, Oncologia Medica
Bari, BA, Italy

Clareo Health | Pathway to Diagnosis of Ovarian Cancer